Related Experiment Video
Updated: Feb 22, 2026

A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
Transcranial Photobiomodulation Modulates Oxidative Stress Biomarkers and Complex IV Activity in Anhedonic-Like
Luciana Bortoluzzi1,2,3, Rafael Colombo2, Karoline Borges da Motta Pinto2
1Postgraduate Program in Biological Sciences, Pharmacology and Therapeutics - Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Transcranial photobiomodulation (tPBM) using red or infrared light improved depressive-like behaviors and biological markers in a rat model. This non-invasive treatment shows promise for managing major depressive disorder by reducing oxidative stress and boosting mitochondrial function.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Pharmacology
Background:
- Major depressive disorder (MDD) is a widespread condition with suboptimal treatment outcomes.
- Transcranial photobiomodulation (tPBM) is an emerging non-invasive therapy using red to near-infrared light, but its mechanisms and optimal parameters require further investigation.
- The chronic mild stress (CMS) model effectively simulates MDD-like phenotypes in rodents.
Purpose of the Study:
- To investigate the effects of red and infrared tPBM on behavioral and biological parameters in a CMS-induced rat model of MDD.
- To explore the potential of tPBM in ameliorating oxidative stress and enhancing mitochondrial function as mechanisms for treating MDD.
Main Methods:
- Male Wistar rats were subjected to CMS for five weeks, then categorized into resilient (CMS-R) and susceptible (CMS-S) groups.
- CMS-S rats received sham treatment, red tPBM (600 nm), or infrared tPBM (840 nm). A non-stressed control group was included.
- Behavioral assessment (sucrose consumption test) and biological analyses (TBARS, TEAC, CCO, NO) in the prefrontal cortex and blood were performed.
Main Results:
- Both red and infrared tPBM significantly increased sucrose consumption in CMS-S rats compared to sham treatment.
- Red tPBM reduced peripheral lipid damage (TBARS) to levels similar to non-stressed controls.
- Infrared tPBM increased hippocampal nitric oxide (NO) levels and prefrontal cortex mitochondrial complex IV (CCO) activity, with CCO levels comparable to controls.
Conclusions:
- tPBM, using either red or infrared wavelengths, demonstrates significant efficacy in improving both behavioral and biological parameters in a rodent model of MDD.
- tPBM therapy holds promise for MDD management by mitigating oxidative stress and improving mitochondrial function.
- Further research into tPBM's therapeutic potential for major depressive disorder is warranted.
More Related Videos
07:56Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
Published on: June 28, 2024
08:16Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015